Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Gastroenterology,Oncology
Reference41 articles.
1. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203;Gérard;J Clin Oncol,2006
2. Preoperative Vs. postoperative chemoradiotherapy for locally advanced rectal cancer: results of the german CAO/ARO/AIO-94 RANDOMIZED PHASE III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012
3. Watch-and-wait approach vs. surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis;Renehan;Lancet Oncol,2016
4. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis;Chadi;Lancet Gastroenterol Hepatol,2018
5. Contribution of the immune system to the chemotherapeutic response;McDonnell;Semin Immunopathol,2011
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Are the tumor microenvironment characteristics of pretreatment biopsy specimens of colorectal cancer really effectively predict the efficacy of neoadjuvant therapy: A retrospective multicenter study;Medicine;2024-08-30
2. Unraveling the causal role of immune cells in gastrointestinal tract cancers: insights from a Mendelian randomization study;Frontiers in Immunology;2024-03-12
3. Intratumoral Budding and CD8-Positive T-cell Density in Pretreatment Biopsies as a Predictor of Response to Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer;Clinical Colorectal Cancer;2023-12
4. Implications of Rectal Cancer Radiotherapy on the Immune Microenvironment: Allies and Foes to Therapy Resistance and Patients’ Outcome;Cancers;2023-10-24
5. CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy;OncoImmunology;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3